Methodology
Evidence first. Objectives explicit. Claims bounded.
AlphaSeek is being developed as an investment-intelligence system spanning research, underwriting, opportunity ranking, portfolio lifecycle, recovery monitoring, and decision review. The governing product direction emphasizes transparent evidence, explicit uncertainty, objective-specific scoring, and separation between analytical state and execution authority.
Provenance before precision
Critical inputs are expected to carry source, as-of information, and confidence context where the underlying product surface supports it.
Objective before score
A multi-bagger screen, compounder score, income lens, valuation lens, and recovery assessment answer different questions. AlphaSeek keeps the investment objective explicit before interpreting a score.
Missing is not zero
A missing critical metric should remain unknown or unavailable. AlphaSeek is designed to avoid manufacturing certainty from incomplete inputs.
Evidence classes stay separate
Historical, hypothetical, shadow, paper, demo, and live observations answer different questions and should not be promoted into one another.
Capital must compete
A strong company, current holding, recovered former position, or new candidate should be compared with alternative uses of capital rather than evaluated in isolation.
Explain the binding evidence
The product direction favors showing what changed, what remains unresolved, and which evidence is driving the current research, portfolio, or lifecycle state.
Current public-preview boundary
The website and demo do not represent a validated investment-performance claim, personalized investment advice, legal clearance, or authorization for automated customer execution. Product scope remains subject to customer evidence, provider rights, qualified legal review, security validation, and governed performance evidence.